🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

59,53 USD

Máx. histórico

2.925,00

12010 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,96%

Rango 52 semanas

37,06 – 95,49

Variación hoy

-0,07%

Cierre anterior

59,57

Rango de hoy

59,25 – 60,89

Volumen hoy

1.327.132

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,88%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 9 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/10/2025 37,58 37,87 36,29 36,54 -2,56% 4,20% 2.429.800
06/10/2025 36,67 39,42 36,64 37,50 +3,82% 7,58% 2.694.200
03/10/2025 35,00 36,24 34,79 36,12 +4,39% 4,14% 1.958.100
02/10/2025 35,45 35,65 34,47 34,60 -1,17% 3,33% 2.011.300
01/10/2025 34,54 35,40 34,38 35,01 +1,51% 2,95% 1.895.500
30/09/2025 33,88 34,61 33,55 34,49 +2,10% 3,13% 2.530.000
29/09/2025 33,39 34,16 33,02 33,78 +2,99% 3,41% 1.791.800
26/09/2025 31,76 32,86 31,46 32,80 +3,60% 4,42% 1.857.400
25/09/2025 32,27 33,13 31,53 31,66 -3,56% 4,96% 2.362.200
24/09/2025 32,91 33,73 32,39 32,83 +1,02% 4,07% 2.359.300
23/09/2025 32,06 33,00 31,59 32,50 +1,40% 4,39% 2.575.300
22/09/2025 30,81 32,17 30,71 32,05 +4,43% 4,75% 2.249.500
19/09/2025 31,53 31,67 30,25 30,69 -2,60% 4,50% 4.938.000
18/09/2025 29,85 31,62 29,81 31,51 +8,17% 6,06% 2.758.500
17/09/2025 29,55 30,40 29,04 29,13 -0,99% 4,60% 1.873.700
16/09/2025 28,75 29,45 28,48 29,42 +2,62% 3,37% 1.992.500
15/09/2025 29,70 29,91 28,12 28,67 -3,53% 6,03% 2.227.100
12/09/2025 29,65 31,13 29,51 29,72 +0,00% 5,46% 3.044.900
11/09/2025 28,70 29,80 27,94 29,72 +2,87% 6,48% 2.710.000
10/09/2025 28,02 29,08 27,80 28,89 +4,18% 4,57% 2.620.900
09/09/2025 27,42 27,82 27,15 27,73 +2,06% 2,44% 2.394.800
08/09/2025 28,37 28,75 27,10 27,17 -6,55% 5,82% 3.267.600
05/09/2025 28,24 29,28 28,01 29,08 +3,84% 4,50% 2.717.100
04/09/2025 28,00 29,34 27,28 28,00 +0,72% 7,36% 3.372.900
03/09/2025 25,75 27,86 25,61 27,80 +8,26% 8,74% 5.385.800
02/09/2025 22,73 26,13 22,73 25,68 +16,57% 14,96% 6.168.900
29/08/2025 22,43 22,55 21,61 22,03 -1,39% 4,19% 2.388.700
28/08/2025 21,81 22,75 21,73 22,34 +2,52% 4,68% 2.477.000
27/08/2025 21,06 21,82 21,06 21,79 +2,88% 3,58% 2.248.000
26/08/2025 20,69 21,23 20,59 21,18 +2,27% 3,09% 1.819.400